Aurdan Capital Management LLC Trims Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Aurdan Capital Management LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 10.7% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,270 shares of the healthcare conglomerate's stock after selling 2,063 shares during the period. UnitedHealth Group makes up about 3.4% of Aurdan Capital Management LLC's investment portfolio, making the stock its 8th largest position. Aurdan Capital Management LLC's holdings in UnitedHealth Group were worth $9,045,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Citizens National Bank Trust Department boosted its position in UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock valued at $9,368,000 after buying an additional 170 shares during the last quarter. Fort Washington Investment Advisors Inc. OH grew its position in shares of UnitedHealth Group by 0.3% in the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock valued at $277,641,000 after purchasing an additional 1,465 shares during the period. Sherbrooke Park Advisers LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth approximately $515,000. Full Sail Capital LLC boosted its holdings in shares of UnitedHealth Group by 2.1% in the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after buying an additional 33 shares during the period. Finally, Soros Fund Management LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $39,413,000. 87.86% of the stock is owned by institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the company's stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the transaction, the director owned 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders acquired 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is currently owned by insiders.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock traded down $3.76 during trading on Thursday, reaching $299.15. The company's stock had a trading volume of 11,314,114 shares, compared to its average volume of 7,662,255. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The business's 50-day moving average price is $318.44 and its 200-day moving average price is $443.71. The firm has a market cap of $271.37 billion, a PE ratio of 12.53, a P/E/G ratio of 1.45 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same period in the prior year, the company earned $6.91 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.96%. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.

Analysts Set New Price Targets

Several research firms have issued reports on UNH. Deutsche Bank Aktiengesellschaft dropped their price target on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research note on Wednesday, May 14th. Oppenheimer cut their target price on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a research note on Wednesday, May 14th. Erste Group Bank downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. Wolfe Research decreased their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research report on Tuesday, May 20th. Finally, Wells Fargo & Company reissued an "overweight" rating on shares of UnitedHealth Group in a research report on Friday, June 6th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $415.00.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.